Skin-Nervous system interactions

Journal of Investigative Dermatology

Volumn 106, Issue 1, 1996, Pages 198-204

  Ansel, John C ^a   Kaynard, Alan H ^b   Armstrong, Cheryl A ^a   Olerud, John ^c   Bunnett, Nigel ^d   Payan, Donald ^e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Kepri Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; HUMAN; HUMAN TISSUE; INFLAMMATION; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN; WOUND HEALING;

EID: 0030019907     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12330326     Document Type: Article

References (188)

1. Bernstein J: Neuropeptides and the skin. In: Goldsmith L (ed.). Physiology, Biochemistry, and Molecular Biology of the Skin. Oxford University Press, New York, 1991, pp 816-835
2. Eedy D: Neuropeptides in skin. Br J Dermatol 128:597-605, 1993
3. Hosoi J, Murphy G, Egan C, Lerner E, Grabbe S, Asahina A, Granstein R: Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159-163, 1993
4. Baraniuk J, Marek L, Kowalski L, Kaliner M: Neuropeptides in the skin. In: Bos J (ed.). Skin Immunology. CRC Press, Boca Raton, 1990, pp 307-326
5. Pincelli C, Rantini F, Giannetti A: Neuropeptides and skin inflammation. Dermatology 187:153-158, 1993
6. Holzer P: Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739-768, 1988
7. Chapman L, Goodell H: The participation of the nervous system in the inflammatory reaction. Ann NY Acad Sci 116:990-1017, 1964
8. Jancsó N, Jancsó-Gábor A, Szolcsányi J: Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31:138-51, 1967
9. Foreman J, Jordan C: Neurogenic inflammation. Trends Pharmacol Sci 5:116-119, 1984
10. Nilsson J, von Euler A, Dalsgaard C-J: Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:61-63, 1985
11. Tanaka T, Danno K, Ikai K, Imamura S: Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 90:399-401, 1988
12. Skofitsch G, Jacobowitz D: Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides 6:747-754, 1985
13. Brain S, Williams T, Tippins J, Morris H, MacIntyre I: Calcitonin gene-related peptide is a potent vasodilator. Nature 313:54-56, 1985
14. Haegerstrand A, Dalsgaard C-J, Jonzon B, Larsson O, Nilsson J: Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 87:3299-3303, 1990
15. Dalsgaard C-J, Hägerstrand A, Theodorsson-Norheim E, Brodin E, Hökfelt T: Neurokinin A-like immunoreactivity in rat primary sensory neurons: coexistence with substance P. Histochemistry 83:37-39, 1985
16. Nilsson J, Sejersen T, Nilsson A, Dalsgaard C-J: DNA synthesis induced by the neuropeptide substance K correlates to the level of myc-gene transcripts. Biochem Biophys Res Commun 137:167-174, 1986
17. 2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol 77:505-509, 1982
18. Leah H, Cameron A, Kelly W, Snow P: Coexistence of peptide immunoreactivity in sensory neurons of the cat. Neuroscience 16:683-690, 1985
19. Haegerstrand A, Jonzon B, Dalsgaard C-J, Nilsson J: Vasoactive intestinal polypeptide stimulates cell proliferation and adeylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 86:5993-5996, 1989
20. 4 mitogenicity toward cultured human keratinocytes. J Invest Dermatol 100:132-136, 1993
21. Barber R, Vaughn J, Slemmon J, Salvaterra P, Roberts E, Leeman S: The origin, distribution and synaptic relationships of substance P axons in rat spinal cord. J Comparative Neurol 184:331-351, 1979
22. Ulrich A, Gray A, Berman C, Dull T: Human beta-nerve growth factor gene sequence is highly homologous to that of mouse. Nature 303:821-825, 1983
23. Diamond J, Holmes M, Coughlin M: Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J Neurosci 12:1454-1466, 1992
24. Kalcheim C, Barde Y-A, Thoenen H, Le Douarin N: In vivo effect of brain-derived neurotrophic factor on the survival of developing dorsal root ganglion cells. EMBO J 6:2871-2873, 1987
25. Leibrock J, Lottspeich F, Hohn A. et al: Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149-152, 1989
26. Ernfors P, Ibánez C, Ebendal T, Oison L, Persson H: Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87:5454-5458, 1990
27. Berkemeier L, Winslow J, Kaplan D, Nikolics K, Goeddel D, Rosenthal A: Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7:857-866, 1991
28. Tron V, Coughlin M, Jang D, Stanisz J, Sauder D: Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 85:1085-1089, 1990
29. Di Marco E, Marshisio P, Bondanza S, Franzi A, Cancedda R, De Luca M: Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 266:21718-21722, 1991
30. Hokfelt T, Johansson O, Ljungdahl A, Lundberg J, Schultzberg M: Petidergic neurons. Nature 284:515-521, 1980
31. Pernow B: Substance P. Pharmacol Rev 35:85-141, 1983
32. Pickel V, Reis D, Leeman SE: Ultrastructural localization of substance P in neurons of rat spinal cord. Brain Res 122:534-540, 1977
33. Nawa H, Kotani H, Nakanishi S: Tissue-specific generation of two preoprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312:729-734, 1984
34. Lynch D, Snyder S: Neuropeptides: multiple molecular forms, metabolic pathways, and receptors. Annu Rev Biochem 55:773-799, 1986
35. Tatemoto K, Lundberg J, Jörnvall H, Mutt V: Neropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun 128:947-953, 1985
36. Nakanishi S: Substance P precursor and Kininogen: their structures, gene organizations, and regulation. Physiol Rev 67:1117-1142, 1987
37. Burcher E, Buck SH: Multiple binding sites in hamster, rat, and guinea-pig urinary bladder. Eur J Pharmacol 1986;128:165-177
38. Muramatsu I, Nakanishi S, Fujiwara M: Comparison of the responses to the sensory neuropeptides, substance P, neurokinin A, neurokinin B and calcitonin gene-related peptide and to trigeminal nerve stimulation in the iris sphincter muscle of the rabbit. Jpn J Pharmacol 44:85-92, 1987
39. Roques B, Fournic-Zaluski M, Soroca E, Lecomte J, Malfroy B, Llorens C: The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288:286-288, 1980
40. Matsas R, Fulcher I, Kenny A, Turner A: Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopetidase of kidney microvilli. Proc Natl Acad Sci USA 80:3111-3115, 1983
41. Matsas R, Kenny A, Turner A: The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues. Biochem J 1984;223:433-440, 1984
42. Hershey A, Krause J: Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 247:958-962, 1990
43. Hershey A, Dykema P, Krause J: Organization, structure, and expression of a gene encoding the rat substance P receptor. J Biol Chem 266(7):4366-4374, 1991
44. Takeda Y, Chou K, Taked J, Sachais B, Krause J: Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun 179:1232-1240, 1991
45. Sasai Y, Nakanishi S: Molecular characterization of rat substance K receptor and its mRNAs. Biochem Biophys Res Commun 165:695-702, 1989
46. Gerard N, Edy RJ, Shows T, Gerard C: The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosomal localization, and isolation of cDNA from tracheal and gastric tissues. J Biol Chem 265:20455-20462, 1990
47. Maggio J: Tachykinins. Annu Rev Neurosci 11:13-28, 1988
48. Quirion R, Dam T: Multiple neurokinin receptors: recent developments. Regul Pept 22:18-25, 1988
49. Helke C, Krause J, Mantyh P, Couture R, Bannon M: Diversity in tachykinin peptidergic neurons: multiple peptides, receptors and regulatory mechanisms. FASEB J 4:1606-1615, 1990
50. Tsuchida K, Shigemoto R, Yokota Y, Nakanishi S: Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur J Biochem 193:751-757, 1990
51. Buck S, Heike C, Burcher E, Shults C, O'Donohue T: Pharmacologic characterization and au to radio graphic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides 7:1109-1120, 1986
52. Saffroy M, Beaujouan J-C, Torrens Y, Besseyre J, Bergström L, Glowinski J: Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides 9:227-241, 1988
53. Mantyh P, Gates T, Mantyh C, Maggio J: J Neurosci 9:258-279, 1989
54. Hershey A, Plenzani L, Woodward R, Miledi R, Krause J: Molecular and genetic characterization, functional expression, and mRNA expression patterns of a rat substance P receptor. Ann NY Acad Sci 632:63-78, 1991
55. Krause J, Takeda Y, Hershey A: Structure, functions, and mechanisms of substance P receptor action. J Invest Dermatol 98:2S-7S, 1992
56. Ansel J, Brown J, Payan D, Brown M: Substance P selectively activates TNF-a gene expression in murine mast cells. J Immunol 150:1-8, 1993
57. Brown J, Perry P, Hefeneider S, Ansel J: Neuropeptide modulation of keratinocyte cytokine production. In: Oppenheim, Powanda, Kluger, Dinarello (eds.). Molecular and Cellular Biology of Cytokines. Wiley-Liss, Inc., 1990, pp 451-456
58. Matis W, Lavker R, Murphy G: Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 94:492-495, 1990
59. Greeno E, Mantyh P, Vercellotti G, Moldow C: Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 45:1269-1276, 1992
60. Phillis J, Limacher J: Substance P excitation of cerebral cortical Betz cells. Brain Res 69:158-163, 1974
61. Rivier C, Brown M, Vale W: Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat. Endocrinology 100:751-754, 1977
62. Vijayan E, McCann S: In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 105:64-68, 1979
63. Eckstein N, Wehrenberg W, Louis K, Carmel P, Zimmermann E, Frantz A: Effects of substance P on anterior pituitary secretion in the female rhesus monkey. Neuroendocrinology 31:338-342, 1980
64. Arisawa M, De Palatis L, Ho R, et al: Stimulatory role of substance P on gonadotropin release in ovariectomized rats. Neuroendocrinology 51:523-529, 1990
65. Traczyk W, Pau K-YF, Kaynard A, Spies H: Modulatory role of substance P on gonadotropin and prolactin secretion in the rabbit. J Physiol Pharmacol 43:279-298, 1992
66. Hedner T, Hedner J, Jonason J, Lundberg D: Evidence suggesting a role for substance P in central respiratory regulation in the rat. Acta Physiologica Scandinavica 1981;112:487-489, 1981
67. Yamamoto Y, Lagercrantz H, von Euler C: Effects of substance P and TRH on ventilation and pattern ot breathing in newborn rabbits. Acta Physiologica Scandinavica 113:541-543, 1981
68. Rossell S, Bjorkroth U, Chang D, et al. In: von Euler U, Pernow B (eds.). Substance P. Raven Press, New York, 1977, p 83
69. Bury R, Mahford M: Interactions between local anesthetics and spasmogens on the guinea-pig ileum. J Pharmacol Exp Ther 197:633-640, 1976
70. Lundberg J, Saria A, Brodin E, Rosell S, Folkers K: A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci USA 80:1120-1124, 1983
71. Lundberg J, Saria A: Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. Acta Physiologica Scandinavica 116:473-476, 1982
72. Lundberg J, Saria A: Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 302:251-253, 1983
73. Bernstein J, Hamill J: Substance P. J Invest Dermatol 77:250-251, 1981
74. 4-macromolecules from ferret trachea. Exp Lung Res 12:21-36, 1987
75. Liang T, Cascieri M: Substance P stimulation of amylase release by isolated parotid cells and inhibition of substance P induction of salivation by vasoactive peptides. Mol Cell Endocrinol 15:151-162, 1979
76. Sjodin L, Conlon T, Gustavson C, Uddholm K: Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Acta Physiologica Scandinavica 120:21-26, 1984
77. Brown M, Vale W: Effects of neurotensin and substance P on plasma insulin, glucagon, and glucose levels. Endocrinology 98:819-822, 1976
78. Kaneto A, Kaneko T, Kajinuma H, Kosaka K: Effects of substance P and neurotensin infused intrapancratically on glucagon and insulin secretion. Endocrinology 102:393-401, 1978
79. Lundquist I, Sundler F, Ahren B, Alumets J, Hakanson R: Somatostatin, pancreatic polypeptide, substance P, and neurotensin: cellular distribution and effects on stimulated insulin secretion in the mouse. Endocrinology 104:832-838, 1979
80. Skrabanek P, Cannon D, Kirrane J, Legge D, Powell D: Circulating immunoreactive substance P in man. Irish J Med Sci 145:399-408, 1976
81. Powell D, Skrabanek P, Cannon D: In: von Euler U, Pernow B (eds.). Substance P. Raven Press, New York, 1977, p 35
82. Powell D, Skrabanek P, Cannon D, Balfe A: In: Marsan C, Traczyk W (eds.). Neuropeptides and Neural Transmissions. Raven Press, New York, 1980, p 105
83. Pernow B, Rosell S: Effect of substance P on blood flow in canine adipose tissue and skeletal muscle. Acta Physiologica Scandinavica 93:139-141, 1975
84. Burcher E, Atterhog J, Pernow B, Rosell S: In: von Euler U, Pernow B (eds.). Substance P. Raven Press, New York, 1977, p 261
85. Eklund B, Jogenstrand T, Pernow B: In: von Euler U, Pernow B (eds.). Substance P. Raven Press, New York, 1977, p 275
86. Hokfelt T, Kellerth J, Nilsson G, Pernow B: Substance P: localization in the central nervous system and in some primary sensory neurons. Science 190:889-890, 1975
87. Bolton T, Clapp L: Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol 87:713-715, 1986
88. Cuello A, Del Fiacco M, Paxinos G: The central and peripheral ends of the substance P-containing sensory neurons in the rat trigeminal system. Brain Res 152:499-500, 1978
89. Bill A, Stjernschantz J, Mandahl A, Brodin E, Nilsson G: Substance P: release on trigeminal nerve stimulation, effects in the eye. Acta Physiologica Scandinavica 106:371-373, 1979
90. Olgart L, Gazelius B, Brodin E, Nilsson G: Release of substance P-like immunoreactivity from the dental pulp. Acta Phystologica Scandinavica 101:510-512, 1977
91. Lembeck F, Holzer P: Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 310:175-183, 1979
92. Erjavec F, Lembeck F, Florjanc-Irman T, et al. Release of histamine by substance P. Naunyn Schmiedeberg's Arch Pharmacol 317:67-70, 1981
93. Coutts A, Jorizzo J, Greaves M, Burnstock G: Mechanism of vasodilatation due to substance P in humans. Br J Dermatol 105:354-355, 1981
94. Devillier P, Regoli D, Asseraf A, Descours B, Marsac J, Renoux M: Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins. Pharmacology 32:340-347, 1986
95. Hagermark O, Hokfelt T, Pernow B: Flare and itch induced by substance P in human skin. J Invest Dermatol 71:233-235, 1978
96. Barnes P, Brown M, Dollery C, Fuller R, Heavey D, Ind P: Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol 88:741-745, 1986
97. Foreman J, Jordan C, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheat and flare reactions in human skin. J Physiol 335:449-465, 1983
98. Payan D, Brewster D, Goetzl E: Specific stimulation of human T lymphocytes by substance P. J Immunol 131:1613-1615, 1983
99. Stanisz A, Befus D, Bienenstock J: Differential effect of vasoactive intestinal polypeptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 136:152-156, 1987
100. Scicchitano R, Bienenstock J, Stanisz A: In vivo immunomodulation by the neuropeptide substance P. Immunology 63:733-735, 1988
101. Levine J, Clark R, Devor M, Helms C, Moskowitz M, Basbaum A: Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226:547-549, 1984
102. Pascual D, Xu-Amano J, Kiyono H, McGee J, Bout K: Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J Immunol 146:2130-2136, 1991
103. McGillis J, Mitsuhashi M, Payan D: Immunologic properties of substance P. In: Ader R, Felten D, Cohen N (eds.). Psychoneuroimmunology. Academic Press, San Diego, 1991, pp 209-223
104. Sudduth-Klinger J, Gilbert M, Bunnett N, Payan D: Characterization of a stable lymphocyte cell line transfected with the substance P receptor cDNA (submitted)
105. Calvo C-F, Chavenel G, Senik A: Substance P enhances IL-2 expression in activated human T cells. J Immunol 148:3498-3504, 1992
106. Payan D, Levine J, Goetzl E: Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 132:1601-1604, 1984
107. Baxter J, Adamik R: Differences in requirements and actions of various histamine-releasing agents. Biochem Pharmacol 27:497-503, 1978
108. Hartung H, Toyka K: Activation of macrophages by substance P: induction of oxidative burst and thromboxane release. Eur J Pharmacol 89:301-305, 1983
109. Payan D: Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. Biochem Biophys Res Commun 130:104-109, 1985
110. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alesandri G: Substance P stimulated neovascularization in vivo and proliferation of cultured endothelial cells. Microvascular Res 40:264-266, 1990
111. Silver A: The Biology of Cholinesterases. Elsevier, Amsterdam, 1974
112. Iversen L: In: Iversen L, Iversen S, Synder S (eds.). Handbook of Psychopharmacology, Vol. 3. Plenum Press, New York, 1978, pp 381-442
113. Bunnett N: Release and breakdown. Postsecretory metabolism of peptides. Am Rev Respiratory Dis 136:S27-S34, 1987
114. Wong-Leung Y, Kenny A: Some properties of a microsomal peptidase in rat kidney. Biochem J 110:5P, 1968
115. Kerr M, Kenny A: The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J 137:477-488, 1974
116. Kerr M, Kenny A: The molecular weight and properties of a neutral metaloendopeptidase from rabbit kidney brush border. Biochemical J 137:489-495, 1974
117. Malfroy B, Swerts J, Guyon A, Roques B, Schwartz J: High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 276:523-526, 1978
118. Matsas R, Kenny A, Turner A: The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins, and their analogs, by endopeptidase 24.11. Biochem J 223:433-440, 1984
119. Turner A: Chapter 10. In: Turner A (ed.). Neuropeptides and Their Peptidases. VCH Publishers, New York, 1987, pp 183-201
120. Bunnett N, Turner A, Hryszko J, Kobayashi R, Walsh J: Isolation of endopeptidase-24.11 (EC3.4.24.11, "enkephalinase") from the pig stomach. Gastroenterology 95:952-957, 1988
121. de la Baume S, Gros C, Yi C, et al: Selective participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins. Life Sci 31:1753-1766, 1982
122. Waksman G, Bouboutou R, Devin J, et al. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur J Pharmacol 117:233-243, 1985
123. Caillet P, Marcais-Collado H, Costentin J, Yi C, de la Baume S, Schwartz J: Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. Eur J Pharmacol 86:329-336, 1983
124. Erdos E, Skidgel R: Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 3:145-151, 1989
125. Dusser D, Umeno E, Graf P, Djokic T, Borson D, Nadel J: Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo. J Appl Physiol 65:2585-2591, 1988
126. Kohrogi H, Graf P, Sekizawa K, Borson D, Nadel J: Neutral endopeptidase inhibitors potentiate substance P- and capsaicin-induced cough in awake guinea pigs. J Clin Invest 82:2063-2068, 1988
127. Umeno E, Nadel J, Huang H-T, McDonald D: Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat trachea. J Appl Physiol 66:2647-2652, 1989
128. Shipp M, Tarr G, Chen C-Y, et al. CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88:10662-10666, 1991
129. Shipp M, Stefano G, D'Adamio L, et al. Down-regulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 347:394-396, 1991
130. Borson D, Brokaw J, Sekizawa K, McDonald D, Nadel J: Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 66:2653-2658, 1989
131. Hwang L, Leichter R, Okamoto A, Payan D, Collins S, Bunnett N: Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine. Am J Physiol 264:G735-G743, 1993
132. Borson D, Gruenert D: Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells. Am J Physiol 260:L83-L89, 1991
133. Ihara H, Nakanishi S: J Biol Chem 265:22441-22445, 1990
134. Cohen S, Levi-Montalcini R, Hamburger V: A nerve growth stimulating factor isolated from sarcoma 37 and 180. Proc Natl Acad Sci USA 40:1014-1018, 1954
135. Levi-Montalcini R: The nerve growth factor: thirty-five years later. EMBO J 6:1145-1154, 1987
136. Greene L, Shooter E: The nerve growth factor: biochemistry, synthesis, and mechanism of action. Annu Rev Neurosci 3:353-402, 1980
137. Heumann R, Korsching S, Scott J, Thoenen H: Relationship between level so nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral targe tissues. EMBO J 3:3183-3189, 1984
138. Whittemore S, Ebendal T, Larkfors L, et al. Developmental regional expression of β nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci USA 83:817-821, 1986
139. Yaar M, Grossman K, Eller M, Gilchrest B: Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 115:821-828, 1991
140. Sutter A, Riopelle R, Harris-Warrick R, Shooter E: Nerve growth factor receptors: characterization of two distinct classes of binding sites on chick embryo sensory ganglion cells. J Biol Chem 254:5972-5982, 1979
141. Bothwell M: Keeping track of neurotrophin receptors. Cell 65:915-918, 1991
142. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M: The trk proto-oncogene encodes a receptor to nerve growth factor. Cell 65:189-197, 1991
143. Kaplan D, Hempstead B, Martin-Zanca D, Chao M, Parada L: The trk protooncogene product: a signal transducing receptor for nerve growth factor. Science 252:554-558, 1991
144. Levi-Montalcini R, Angeletti P: Essential role of the nerve growth factor in the survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells m vitro. Dev Biol 7:653-659, 1963
145. Johnson E, Gorin P, Bandeis L, Pearson J: Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibodies to nerve growth factor. Science 210:916-918, 1980
146. Ross M, Lofstrandh S, Gorin P, Johnson E, Schwartz J: Use of an experimental autoimmune model to define nerve growth factor dependency of peripheral and central substance P containing neurons in the rat. J Neurosci 1:1304-1311, 1981
147. Stockel K, Schwab M, Thoenen H: Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological study. Brain Res 89:1-14, 1975
148. Schwartz J, Pearson J, Johnson E: Effect of exposure to anti-NGF on sensory neruons of adult rats and guinea pigs. Brain Res 244:378-381, 1982
149. Waris T: Reinnervation of free skin autografts in the rat. Plastic Reconstruct Surg 12:85-93, 1978
150. Waris T: Degeneration and regeneration of nerves in a dorsal skin flap in the rat. Scand J Plastic Reconstruct Surg Hand Surg 12:95-103, 1978
151. Kishimoto S, Maruo M, Ohse C, et al: The regeneration of the sympathetic catecholaminergic nerve fibers in the process of burn wound healing in guinea pigs. J Invest Dermatol 79:141-146, 1982
152. Kishimoto S: The regeneration of substance F-containing nerve fibers in the process of burn wound healing in the guinea pig skin. J Invest Dermatol 83:219-223, 1984
153. Aldskogius M, Hermanson A, Jonsson C-E: Reinnervation of experimental superficial wounds in rats. Plastic Reconstruct Surg 79:595-599, 1987
154. Devor M, Schonfeld D, Seltzer Z, Wall P: Two modes of cutaneous reinnervation following peripheral nerve injury. J Compar Neurol 185:211-220, 1979
155. Owen D, Logan A, Robinson P: A role for nerve growth factor in collateral reinnervation from sensory nerves in the guinea pig. Brain Res 470:150-160, 1989
156. Doubleday B, Robinson P: The rule of nerve growth factor in collateral reinnervation by cutaneous C-fibers in the rat. Brain Res 593:179-184, 1992
157. Wilson P, Scott J, Penschow J, Coghlan J, Rush R: Identification and quantification of mRNA for nerve growth factor in histological preparations. Neurosci Lett 64:323-329, 1986
158. Taniuchi M, Clark H, Johnson E: Induction of nerve growth factor receptor in Schwann cells after axotomy. Proc Natl Acad Sci USA 83:4094-4098, 1986
159. Assouline J, Bosch P, Lim R, Kim I, Jensen R, Pantazis N: Rat astrocytes and Schwann cells in culture synthesize nerve growth factor like neurite-promoting factors. Dev Brain Res 31:103-118, 1987
160. Taniuchi M, dark H, Schucitzer J, Johnson EJ: Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: ultrastructural location, suppresion by axonal contact binding properties. J Neurosci 8:664-681, 1988
161. Diamond J, Foerster A, Holmes M, Coughlin M: Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J Neurosci 12:1467-1476, 1992
162. Pearce F, Thompson H: Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 372:379-393, 1986
163. Matsuda H, Coughlin M, Bienenstock J, Denburg J: Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 85:6508-6512, 1988
164. Otten U, Ehrhard P, Peck R: Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 86:10059-10063, 1989
165. Lewis T, Marvin H: Observations relating to vasodilatation arising from antidromic impulses, to herpes zoster and trophic effects. Heart 14:27-46, 1927
166. Bayliss W: On the origin from the spinal cord of vasodilator fibers of the hind limb, and on the nature of these fibers. J Physiol 26:173-209, 1901
167. Lewis T: The nocifensor system of nerves and its reactions. Br Med J 1:431-435, 1927
168. Johnson P, Doll S: Dermal nerves in human diabetic subjects. Diabetes 33:244-250, 1984
169. Jancsò G, Obál F, Tóth-Kasa I, Katona M, Husz S: The modulation of cutaneous inflammatory reactions by peptide-containing sensory nerves. Int J Tissue Reactions 7:449-457, 1985
170. Olivari N, Schirudde J, Wahle H: The surgical treatment of bedsores in paraplegics. Plastic Reconstruct Surg 50:477-482, 1972
171. Basson M, Burney R: Defective wound healing in patients with paraplegia and quadriplegia. Surg Gynecol Obstet 155:9-12, 1982
172. Lusthaus S, Shoshan S, Benmeir P, Livoff A, Ashur U, Vardy D: Effect of denervation on incision wound scars in rabbits. J Geriatr Dermatol 1:11-14, 1993
173. Nagy J, Iversen L, Goedert M, Chapman D, Hunt S: Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci 3:399-406, 1983
174. Kjartansson J, Dalsgaard C-J, Jonsson C-E: Decreased survival of experimental critical flaps in rats after sensory denervation with capsaicin. Plastic Reconstruct Surg 79:218-221, 1987
175. Shimizu I, Fujita S, Izumi K, Koja T, Ohba N, Fukuda T: Corneal lesions induced hy the systemic administration of capsaicin in neonatal mice and rats. Naunyn-Schmiedrebergs Arch Pharmacol 326:347-351, 1984
176. Duke-Elder S, Leigh A: Diseases of the outer eyes. In: Duke-Elder S (ed.). System of Opthalmology. Henry Kimble, London, 1965, pp 803-810
177. Gallar J, Pozo M, Rebello I, Belmonte C: Effects of capsaicin on coneal wound healing. Invest Ophthalmol Vis Sci 31:1 968-1974, 1990
178. Jonsson C-E, Brodin E, Dalsgaard C-J, Haegerstrand A: Release of substance-P-like Immunoreactivity in dog paw lymph after scalding injury. Acta Physiol Scand 126:21-24, 1986
179. Grönblad M, Korkala O, Konttinen Y, Kuokkanen H, Liesi P: Immunoreactive neuropeptides in nerves in ligamentous tissue. An experimental neuroimmunohistochemical study. Clin Orthopaed Relat Res 265:291-296, 1991
180. Senapati A, Anand P, McGregor G, Ghatei M, Thompson R, Bloom S: Depletion of neuropeptides during wound healing in rat skin. Neurosci Lett 71:101-105, 1986
181. 1-4. Biull Eksp Biol Med 1989;107(6):739-43
182. English K, Stayner N, Krueger G, Tuckett R: Tactile function in skin-equivalent grafts. Exp Neurol 115:104-108, 1992
183. English K, Stayner N, Krueger G, Tuckett R: Functional innervation of cultured skin grafts. J Invest Dermatol 99:120-128, 1992
184. Horch K: The influence of mechanoreceptor structures on regenerating sensory axons after cutaneous nerve transection in the cat. Neurosci Lett 32:281-284, 1982
185. Hartung H, Wolters K, Toyka K: Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol 136:3856-3863, 1986
186. Wiederman C, Wiederman F, Apperl A, Kieselbach G, Konwalinka G, Braunsteiner H: In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P. Arch Pharmacol 340:185-1911, 1989
187. Ruff M, Whal S, Pert C: Substance P receptor-mediated chemotaxis of human monocytes. Peptides 6(suppl): 107-111, 1985
188. Sudduth-Klinger J, Schumann M, Gardner P, Payan D: Functional and immunological responses of Jurkat lymphocytes transfected with the substance P receptor. Cell Mol Neurobiol 12:379-395, 1992